Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management

J Eur Acad Dermatol Venereol. 2008 Mar;22(3):380-2. doi: 10.1111/j.1468-3083.2007.02335.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Autoimmune Diseases / drug therapy
  • Female
  • Foot / pathology
  • Hand / pathology
  • Humans
  • Infliximab
  • Male
  • Practice Guidelines as Topic
  • Psoriasis / chemically induced*
  • Psoriasis / diagnosis*
  • Psoriasis / pathology
  • Scalp / pathology
  • Skin / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab